MicroRNA-22 induces endothelial progenitor cell senescence by targeting AKT3

Cellular Physiology and Biochemistry

Volumn 34, Issue 5, 2014, Pages 1547-1555

  Zheng, Yue ^a   Xu, Zhiwei ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Aging; AKT3; Angiogenesis; Endothelial progenitor cells; Senescence

Indexed keywords

AKT 3 PROTEIN; BETA GALACTOSIDASE; MICRORNA 22; PROTEIN KINASE B; PROTEIN P16; UNCLASSIFIED DRUG; AKT3 PROTEIN, HUMAN; MICRORNA; MIRN22 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ADULT; ANGIOGENESIS; ANGIOGENESIS ASSAY; ANIMAL CELL; ARTICLE; BINDING SITE; BLOOD SAMPLING; BONE MARROW CELL; CELL AGING; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIAL PROGENITOR CELL; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MONONUCLEAR CELL; MOUSE; MTT ASSAY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TARGETING; REAL TIME POLYMERASE CHAIN REACTION; REPORTER GENE; SENESCENCE; SENESCENCE ASSOCIATED BETA GALACTOSIDASE STAINING; STAINING; UPREGULATION; WESTERN BLOTTING; YOUNG ADULT; AGED; AGING; CELL CULTURE; CELL MOTION; GENETICS; METABOLISM; NEOVASCULARIZATION (PATHOLOGY);

ADULT; AGED; AGING; CELL AGING; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; ENDOTHELIAL PROGENITOR CELLS; HUMANS; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; PROTO-ONCOGENE PROTEINS C-AKT; UP-REGULATION; YOUNG ADULT;

EID: 84908279579     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000366358     Document Type: Article

References (35)

1. Carmeliet P: Angiogenesis in life, disease and medicine. Nature 2005;438:932-936.
2. Khoo CP, Pozzilli P, Alison MR: Endothelial progenitor cells and their potential therapeutic applications. Regenerative medicine 2008;3:863-876.
3. Fadini GP, Losordo D, Dimmeler S: Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use. Circ Res 2012;110:624-637.
4. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L, Girardi L, Yurt R, Himel H, Rafii S: Vascular trauma induces rapid but transient mobilization of vegfr2 (+) ac133 (+) endothelial precursor cells. Circ Res 2001;88:167-174.
5. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T: Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nature Med 1999;5:434-438.
6. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, Chadburn A, Heissig B, Marks W, Witte L, Wu Y, Hicklin D, Zhu Z, Hackett NR, Crystal RG, Moore MA, Hajjar KA, Manova K, Benezra R, Rafii S: Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nature Med 2001;7:1194-1201.
7. Toda N: Age-related changes in endothelial function and blood flow regulation. Pharmacol Ther 2012;133:159-176.
8. Zhang J, Zhang Z, Zhang DY, Zhu J, Zhang T, Wang C: microRNA 126 inhibits the transition of endothelial progenitor cells to mesenchymal cells via the PIK3R2-PI3K/Akt signalling pathway. PLoS One 2013;8:e83294.
9. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM: Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: Proof of concept for the clinical importance of endogenous vascular repair. Circulation 2005;111:2981-2987.
10. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA: Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 2004;56:549-580.
11. Chandler H, Peters G: Stressing the cell cycle in senescence and aging. Curr Opin Cell Biol 2013;25:765-771.
12. Salama R, Sadaie M, Hoare M, Narita M: Cellular senescence and its effector programs. Genes Dev 2014;28:99-114.
13. Bartel DP: Micrornas: Genomics, biogenesis, mechanism, and function. Cell 2004;116:281-297.
14. He L, Hannon GJ: Micrornas: Small rnas with a big role in gene regulation. Nat Rev Genet 2004;5:522-531.
15. Suarez Y, Sessa WC: Micrornas as novel regulators of angiogenesis. Circul Res 2009;104:442-454.
16. Urbich C, Kuehbacher A, Dimmeler S: Role of micrornas in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res 2008;79:581-588.
17. Menghini R, Casagrande V, Cardellini M, Martelli E, Terrinoni A, Amati F, Vasa-Nicotera M, Ippoliti A, Novelli G, Melino G, Lauro R, Federici M: Microrna 217 modulates endothelial cell senescence via silent information regulator 1. Circulation 2009;120:1524-1532.
18. Zhao T, Li J, Chen AF: Microrna-34a induces endothelial progenitor cell senescence and impedes its angiogenesis via suppressing silent information regulator 1. Am J Physiol Endocrinol Metabol 2010;299:E110-116.
19. Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo D, Yang F, Wei J, Wang L, Dykxhoorn DM, Hare JM, Goldschmidt-Clermont PJ, Dong C: Microrna-10a∗ and microrna-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group a2. Circul Res 2013;112:152-164.
20. Meng S, Cao JT, Zhang B, Zhou Q, Shen CX, Wang CQ: Downregulation of microrna-126 in endothelial progenitor cells from diabetes patients, impairs their functional properties, via target gene spred-1. J Mol Cell Cardiol 2012;53:64-72.
21. Kang SS, Kwon T, Kwon DY, Do SI: Akt protein kinase enhances human telomerase activity through phosphorylation of telomerase reverse transcriptase subunit. J Biol Chem 1999;274:13085-13090.
22. Scheid MP, Woodgett JR: Unravelling the activation mechanisms of protein kinase b/akt. FEBS Lett 2003;546:108-112.
23. Jazbutyte V, Fiedler J, Kneitz S, Galuppo P, Just A, Holzmann A, Bauersachs J, Thum T: Microrna-22 increases senescence and activates cardiac fibroblasts in the aging heart. Age 2013;35:747-762.
24. Xiong J, Du Q, Liang Z: Tumor-suppressive microrna-22 inhibits the transcription of e-box-containing c-myc target genes by silencing c-myc binding protein. Oncogene 2010;29:4980-4988.
25. Tsuchiya N, Izumiya M, Ogata-Kawata H, Okamoto K, Fujiwara Y, Nakai M, Okabe A, Schetter AJ, Bowman ED, Midorikawa Y, Sugiyama Y, Aburatani H, Harris CC, Nakagama H: Tumor suppressor mir-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21. Cancer Res 2011;71:4628-4639.
26. Ling B, Wang GX, Long G, Qiu JH, Hu ZL: Tumor suppressor mir-22 suppresses lung cancer cell progression through post-transcriptional regulation of erbb3. J Cancer Res Clin Oncol 2012;138:1355-1361.
27. Li B, Song Y, Liu TJ, Cui YB, Jiang Y, Xie ZS, Xie SL: Mirna-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of t-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9. Oncol Rep 2013;29:1932-1938.
28. Guo MM, Hu LH, Wang YQ, Chen P, Huang JG, Lu N, He JH, Liao CG: Mir-22 is down-regulated in gastric cancer, and its overexpression inhibits cell migration and invasion via targeting transcription factor sp1. Medical Oncol 2013;30:542.
29. Xu D, Takeshita F, Hino Y, Fukunaga S, Kudo Y, Tamaki A, Matsunaga J, Takahashi RU, Takata T, Shimamoto A, Ochiya T, Tahara H: Mir-22 represses cancer progression by inducing cellular senescence. J Cell Biol 2011;193:409-424.
30. Gurha P, Abreu-Goodger C, Wang T, Ramirez MO, Drumond AL, van Dongen S, Chen Y, Bartonicek N, Enright AJ, Lee B, Kelm RJ, Jr., Reddy AK, Taffet GE, Bradley A, Wehrens XH, Entman ML, Rodriguez A: Targeted deletion of microrna-22 promotes stress-induced cardiac dilation and contractile dysfunction. Circulation 2012;125:2751-2761.
31. Poliseno L, Salmena L, Riccardi L, Fornari A, Song MS, Hobbs RM, Sportoletti P, Varmeh S, Egia A, Fedele G, Rameh L, Loda M, Pandolfi PP: Identification of the mir-106b∼25 microrna cluster as a proto-oncogenic pten-targeting intron that cooperates with its host gene mcm7 in transformation. Science Signal 2010;3:ra29.
32. Song SJ, Ito K, Ala U, Kats L, Webster K, Sun SM, Jongen-Lavrencic M, Manova-Todorova K, Teruya-Feldstein J, Avigan DE, Delwel R, Pandolfi PP: The oncogenic microrna mir-22 targets the tet2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation. Cell Stem Cell 2013;13:87-101.
33. Song SJ, Poliseno L, Song MS, Ala U, Webster K, Ng C, Beringer G, Brikbak NJ, Yuan X, Cantley LC, Richardson AL, Pandolfi PP: Microrna-antagonism regulates breast cancer stemness and metastasis via tet-familydependent chromatin remodeling. Cell 2013;154:311-324.
34. Bellacosa A, Kumar CC, Di Cristofano A, Testa JR: Activation of akt kinases in cancer: Implications for therapeutic targeting. Adv Cancer Res 2005;94:29-86.
35. Kloet DE, Burgering BM: The pkb/foxo switch in aging and cancer. Biochim Biophys Acta 2011;1813:1926-1937.